GlassScriptPhysician profile
Carol M Steiner
NPI 1982678009
$1,275.55
in general payments reported to CMS, 2019-2025
17 companies · $269 in 2025
The $269 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2021: $43.27 · 2022: $55.85 · 2023: $162 · 2024: $168 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $238.99 | 2019-2025 | |
| Pfizer INC. | $222.03 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $151.94 | 2019 | |
| Corium, LLC | $151.32 | 2022-2024 | Azstarys |
| Kaleo, INC. | $104.27 | 2019-2024 | Auvi-Q |
| Collegium Pharmaceutical, INC. | $59.64 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $56.55 | 2023-2025 | Bexsero, Pediarix, Rotarix |
| Verrica Pharmaceuticals INC. | $41.06 | 2023-2024 | Ycanth |
| Arbor Pharmaceuticals, INC. | $37.42 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.07 | 2025 | Elaprase |
| Seqirus USA INC | $31.61 | 2024-2025 | Flucelvax |
| Tris Pharma INC | $30.46 | 2019 | |
| Mirum Pharmaceuticals, INC. | $26.69 | 2023 | Livmarli |
| Supernus Pharmaceuticals, INC. | $25.24 | 2025 | Qelbree |
| Sanofi-Aventis U.S. LLC | $24.70 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $20.96 | 2025 | Valtoco |
| Astrazeneca Pharmaceuticals LP | $18.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Steiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.